Compugen (CGEN) Assets Growth (3y) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 18.46%
Sep 30, 2025 -0.51%
Jun 30, 2025 -1.16%
Mar 31, 2025 -1.54%
Dec 31, 2024 -4.53%
Sep 30, 2024 0.61%
Jun 30, 2024 -3.56%
Mar 31, 2024 -4.36%
Dec 31, 2023 -4.27%
Sep 30, 2023 -22.16%
Jun 30, 2023 -19.17%
Mar 31, 2023 -13.69%
Dec 31, 2022 20.55%
Sep 30, 2022 20.12%
Jun 30, 2022 31.72%
Mar 31, 2022 33.45%
Dec 31, 2021 35.45%
Sep 30, 2021 33.46%
Jun 30, 2021 34.00%
Mar 31, 2021 49.28%
Dec 31, 2020 52.83%
Sep 30, 2020 44.93%
Jun 30, 2020 37.92%
Mar 31, 2020 26.89%
Dec 31, 2019 -8.91%
Sep 30, 2019 -9.72%
Jun 30, 2019 -17.02%
Mar 31, 2019 -17.74%
Dec 31, 2018 -18.79%
Sep 30, 2018 -19.30%
Jun 30, 2018 -20.93%
Mar 31, 2018 -28.85%
Dec 31, 2017 -30.41%
Sep 30, 2017 -25.66%
Jun 30, 2017 -22.94%
Mar 31, 2017 -20.08%
Dec 31, 2016 7.85%
Sep 30, 2016 12.04%
Jun 30, 2016 31.66%
Mar 31, 2016 39.55%
Dec 31, 2015 50.89%
Sep 30, 2015 51.23%
Jun 30, 2015 51.00%
Mar 31, 2015 49.45%
Dec 31, 2014 58.13%
Sep 30, 2014 58.99%
Jun 30, 2014 55.74%
Mar 31, 2014 54.00%
Dec 31, 2013 15.87%
Sep 30, 2013 23.14%
Jun 30, 2013 8.52%
Mar 31, 2013 1.98%
Dec 31, 2012 -1.43%
Sep 30, 2012 32.65%
Jun 30, 2012 30.45%
Mar 31, 2012 40.25%